Efficacy of coupled plasma filtration adsorption (CPFA) in patients with septic shock: A multicenter randomised controlled clinical trial

BMJ Open

Volumn 4, Issue 1, 2014, Pages

  Livigni, Sergio ^a   Bertolini, Guido ^b   Rossi, Carlotta ^b   Ferrari, Fiorenza ^a   Giardino, Michele ^b   Pozzato, Marco ^a   Remuzzi, Giuseppe ^b  

^a MOLINETTE HOSPITAL   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DROTRECOGIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ATTRIBUTABLE RISK; BLOOD FILTRATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; COUPLED PLASMA FILTRATION ADSORPTION THERAPY; CRITICALLY ILL PATIENT; FEMALE; FOLLOW UP; HUMAN; INTENSIVE CARE; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; PARALLEL DESIGN; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; SEPTIC SHOCK; SURVIVAL RATE; YOUNG ADULT; ADSORPTION; CLINICAL TRIAL; HEMOFILTRATION; PROCEDURES; SHOCK, SEPTIC; TREATMENT OUTCOME;

ADOLESCENT; ADSORPTION; ADULT; AGED; FEMALE; HEMOFILTRATION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SHOCK, SEPTIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84892850933     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003536     Document Type: Article

References (39)

1. Feezor RJ, Oberholzer C, Baker HV, et al. Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria. Infect Immun 2003;71:5803-13. (Pubitemid 37205634)
2. Bozza FA, Salluh JI, Japiassu AM, et al. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 2007;11:R49.
3. Kellum JA, Kong L, Fink MP, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 2007;167:1655-63. (Pubitemid 47280347)
4. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013;369:840-51.
5. Bochud PY, Calandra T. Pathogenesis of sepsis: new concepts and implications for future treatment. BMJ 2003;326:262-6. (Pubitemid 36169594)
6. Weighardt H, Heidecke CD, Emmanuilidis K, et al. Sepsis after major visceral surgery is associated with sustained and interferon-gamma-resistant defects of monocyte cytokine production. Surgery 2000;127:309-15. (Pubitemid 30140629)
7. Tamayo E, Fernandez A, Almansa R, et al. Pro-and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock. Eur Cytokine Netw 2011;22:82-7.
8. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005;365:63-78.
9. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138-50. (Pubitemid 36056721)
10. Cavaillon JM, Annane D. Compartmentalization of the inflammatory response in sepsis and SIRS. J Endotoxin Res 2006;12:151-70. (Pubitemid 47487521)
11. Wang ZM, Liu C, Dziarski R. Chemokines are the main proinflammatory mediators in human monocytes activated by Staphylococcus aureus, peptidoglycan, and endotoxin. J Biol Chem 2000;275:20260-7. (Pubitemid 30457598)
12. Munoz C, Misset B, Fitting C, et al. Dissociation between plasma and monocyte-associated cytokines during sepsis. Eur J Immunol 1991;21:2177-84.
13. Tetta C, Bellomo R, Inguaggiato P, et al. Endotoxin and cytokine removal in sepsis. Ther Apher 2002;6:109-15. (Pubitemid 34507300)
14. Tetta C, Gianotti L, Cavaillon JM, et al. Coupled plasma filtration-adsorption in a rabbit model of endotoxic shock. Crit Care Med 2000;28:1526-33. (Pubitemid 30324535)
15. Ronco C, Brendolan A, Lonnemann G, et al. A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med 2002;30:1250-5. (Pubitemid 34620967)
16. Formica M, Olivieri C, Livigni S, et al. Hemodynamic response to coupled plasmafiltration-adsorption in human septic shock. Intensive Care Med 2003;29:703-8. (Pubitemid 36609560)
17. Human Medicines Evaluation Unit. Guidelines for good clinical practice. London: European Agency for the Evaluation of Medical Products, 1996:17-20.
18. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003;29:530-8. (Pubitemid 36523666)
19. Boffelli S, Rossi C, Anghileri A, et al. Continuous quality improvement in intensive care medicine. The GiVi TI Margherita Project-Report 2005. Minerva Anestesiol 2006;72:419-32.
20. Malacarne P, Langer M, Nascimben E, et al. Building a continuous multicenter infection surveillance system in the intensive care unit: findings from the initial data set of 9,493 patients from 71 Italian intensive care units. Crit Care Med 2008;36:1105-13. (Pubitemid 351482657)
21. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270:2957-63. (Pubitemid 24000804)
22. Vincent JL, de Mendonca A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 1998;26:1793-800. (Pubitemid 28527688)
23. Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204-12.
24. Piantadosi S. Clinical trial. A methodological perspective. New York: Jonh Wiley & Sons, 1997.
25. Schulz KF, Grimes DA. Allocation concealment in randomised trials: defending against deciphering. Lancet 2002;359:614-18. (Pubitemid 34178448)
26. Page M, Rimmele T. [Coupled plasma filtration adsorption: rationale and perspectives in septic shock]. Can J Anaesth 2008;55:847-52.
27. Ronco C, Brendolan A, d'Intini V, et al. Coupled plasma filtration adsorption: rationale, technical development and early clinical experience. Blood Purif 2003;21:409-16. (Pubitemid 37346716)
28. Formica M, Inguaggiato P, Bainotti S, et al. Coupled plasma filtration adsorption. Contrib Nephrol 2007;156:405-10.
29. Kleinbaum D, Kupper L, Morgenstern H. Epidemiologic research. New York, NY: Van Nostrand Reynhold, 1982.
30. Fergusson D, Aaron SD, Guyatt G, et al. Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. BMJ 2002;325:652-4.
31. Prowle JR, Schneider A, Bellomo R. Clinical review: optimal dose of continuous renal replacement therapy in acute kidney injury. Crit Care 2011;15:207.
32. Annane D, Aegerter P, Jars-Guincestre MC, et al. Current epidemiology of septic shock: the CUB-Rea Network. Am J Respir Crit Care Med 2003;168:165-2. (Pubitemid 36920969)
33. Cohen J, Guyatt G, Bernard GR, et al. New strategies for clinical trials in patients with sepsis and septic shock. Crit Care Med 2001;29:880-6. (Pubitemid 32299732)
34. Perl TM, Dvorak L, Hwang T, et al. Long-term survival and function after suspected gram-negative sepsis. JAMA 1995;274:338-45.
35. Singer M, McNally T, Screaton G, et al. Heparin clearance during continuous veno-venous haemofiltration. Intensive Care Med 1994;20:212-15. (Pubitemid 24088586)
36. Zhang Z, Hongying N. Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy. Intensive Care Med 2012;38:20-8.
37. Mariano F, Bergamo D, Gangemi EN, et al. Citrate anticoagulation for continuous renal replacement therapy in critically Ill patients: success and limits. Int J Nephrol 2011;2011:748320. 1-5.
38. Mariano F, Tetta C, Stella M, et al. Regional citrate anticoagulation in critically ill patients treated with plasma filtration and adsorption. Blood Purif 2004;22:313-19. (Pubitemid 39177738)
39. Pozzato M, Ferrari F, Cecere P, et al. Safety and efficacy of citrate anticoagulation in spetic shock patients treated with couplet plasma filtration adsorbtion (CPFA). J Am Soc Nephrol 2011;22-Congress Proceeding:605A.